Oxygen Therapy Market Size & Growth Forecast 2027–2036, By Segments (Product, End Use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Oxygen Therapy Market size was valued at USD 41.55 billion in 2026 and is anticipated to grow at a 6.3% CAGR from 2027 to 2036, exceeding USD 76.54 billion by 2036. The industry revenue for 2027 is calculated at USD 44.02 billion.

• Base Year Value (2026): USD 41.55 billion
• CAGR (2027-2036): 6.30%
• Forecast Year Value (2036): USD 76.54 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Oxygen Therapy Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America accounts for 36.68% share in 2026, supported by established clinical use, strong homecare adoption, structured reimbursement systems, and consistent demand for respiratory treatment devices.
  • Asia Pacific is growing at a 7.91% CAGR, driven by expanding healthcare access, rising hospital oxygen use, home-based therapy adoption, and ongoing infrastructure investments across healthcare systems.

• Segment Momentum:

  • Oxygen Source Equipment held a 61.11% share in 2026 because it provides the essential oxygen supply required for continuous therapy, making it the operational foundation across both healthcare facilities and home care settings.
  • Home Healthcare is both the largest and fastest-growing end-use segment as long-term respiratory care increasingly shifts to home settings, supporting patient convenience and ongoing management of chronic respiratory conditions.

• Market Expansion Drivers:

  • Rising prevalence of COPD and asthma increasing demand for long-term oxygen therapy devices.
  • Growing adoption of home healthcare services accelerating portable oxygen concentrator deployment.
  • Increasing demand for technologically advanced respiratory support systems improving patient mobility and care access.

• Leading Market Participants:

  Leading players in the oxygen therapy market include ResMed Inc. (United States), Koninklijke Philips N.V. (Netherlands), Inogen, Inc. (United States), Drägerwerk AG & Co. KGaA (Germany), Linde plc (Ireland), Chart Industries, Inc. (United States), Fisher & Paykel Healthcare Corporation Limited (New Zealand), GE HealthCare Technologies Inc. (United States), Invacare Corporation (United States), Air Liquide S.A. (France).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 41.55 billion
  • 2027 Estimated Market Size: USD 44.02 billion.
  • Projected Market Size: USD 76.54 billion by 2036
  • Growth Forecasts: 6.3% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Oxygen Source Equipment (Product) | Home Healthcare (End Use) | Chronic Obstructive Pulmonary Disease (Application)
  • Emerging Opportunity Segment: Oxygen Delivery Devices (Product) | Home Healthcare (End Use) | Obstructive Sleep Apnea (Application)

Market Growth Drivers and Industry Trends

Rising prevalence of COPD and asthma increasing demand for long-term oxygen therapy devices

The rising burden of chronic respiratory conditions such as COPD and asthma will drive the oxygen therapy market growth by increasing the need for sustained supplemental oxygen among patients requiring long-term respiratory support. As these conditions can impair oxygen intake and reduce respiratory function, healthcare providers increasingly rely on oxygen delivery devices to support ongoing treatment and symptom management. This sustained clinical requirement supports demand for equipment that can deliver consistent oxygen therapy across different stages of respiratory care.

Growing adoption of home healthcare services accelerating portable oxygen concentrator deployment

The expansion of home-based care is reshaping respiratory treatment delivery, with the oxygen therapy market benefiting from greater use of portable oxygen concentrators outside conventional healthcare facilities. Home healthcare allows patients who require ongoing oxygen support to receive treatment in familiar settings while reducing dependence on frequent facility-based care. Portable concentrators align with this model by providing oxygen delivery in a more convenient format, supporting independent treatment routines and extending respiratory care into residential environments.

Increasing demand for technologically advanced respiratory support systems improving patient mobility and care access

Technological innovation in respiratory support is strengthening the oxygen therapy market as patients and caregivers seek equipment that combines effective oxygen delivery with greater usability and mobility. Advances in device design can make oxygen systems easier to transport and integrate into daily activities, helping patients maintain access to therapy while moving between home, medical appointments, and other settings. Improved portability and user-oriented functionality also support more flexible care arrangements for individuals requiring continuous respiratory assistance.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of COPD and asthma increasing demand for long-term oxygen therapy devices	1.90%	High	North America, Europe, Asia Pacific	High	Near Term
Growing adoption of home healthcare services accelerating portable oxygen concentrator deployment	1.70%	Moderate	North America, Asia Pacific	High	Mid Term
Increasing demand for technologically advanced respiratory support systems improving patient mobility and care access	1.40%	Moderate	Europe, North America	Emerging	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

In the oxygen therapy market, North America held the largest share of 36.68% in 2026, supported by advanced healthcare infrastructure, widespread access to respiratory care, and strong adoption of home-based oxygen therapy solutions. The region's established network of hospitals, specialty clinics, and long-term care facilities facilitates the diagnosis and management of respiratory disorders requiring supplemental oxygen. Rising preference for portable and home-use oxygen systems is also encouraging technological development focused on mobility, ease of use, and patient comfort. In addition, favorable reimbursement environments, established medical-device distribution channels, and continued healthcare investment contribute to the region's strong commercial position.

Asia Pacific represents the fastest-growing regional market, driven by expanding healthcare infrastructure, increasing awareness of respiratory diseases, and improving access to specialized medical equipment. Growing healthcare expenditure and the modernization of hospitals across emerging economies are creating greater opportunities for oxygen concentrators, oxygen delivery systems, and related respiratory-care equipment. Urbanization and changing environmental conditions are also increasing attention toward respiratory health, while the expansion of home healthcare is broadening demand beyond traditional hospital settings. Improvements in medical-device availability and greater emphasis on accessible chronic-disease management are expected to further support regional market development.

Key Country Insights

United States

Home Care Expansion

The U.S. oxygen therapy market increasingly supports home-based respiratory care through portable oxygen systems and connected monitoring technologies. Healthcare providers prioritize patient convenience, long-term disease management, and reliable oxygen delivery solutions across diverse care settings.

Japan

Aging Care Support

Japan expands oxygen therapy adoption as healthcare providers strengthen respiratory care services for an aging population and chronic respiratory conditions. The country prioritizes dependable oxygen delivery technologies that improve treatment continuity in both institutional and home care settings.

South Korea

Connected Respiratory Solutions

South Korea integrates oxygen therapy with digital healthcare technologies to enhance respiratory disease management and remote patient monitoring. Healthcare providers increasingly adopt portable systems that improve treatment accessibility while supporting efficient long-term patient care.

Germany

Respiratory Care Modernization

Germany advances oxygen therapy through investments in high-quality respiratory equipment and integrated clinical care pathways. Healthcare providers increasingly adopt efficient oxygen delivery systems that improve patient management in hospitals and home healthcare environments.

France

Integrated Pulmonary Services

France strengthens oxygen therapy through coordinated respiratory care programs and wider access to home healthcare services. The country promotes efficient oxygen delivery solutions that support long-term patient management while improving continuity between hospital and community care.

Italy

Community Respiratory Care

Italy continues expanding oxygen therapy through greater emphasis on home-based respiratory treatment and chronic disease management. Healthcare providers increasingly adopt reliable oxygen delivery equipment that supports patient mobility and efficient long-term care outside hospital settings.

Segment Leadership and Growth Trends

 

Product Segment Analysis: Oxygen Source Equipment (Largest Segment) vs Oxygen Delivery Devices (Fastest-Growing Segment)

Oxygen source equipment accounted for the largest share of the oxygen therapy market, reaching 61.11% in 2026. The segment benefits from its fundamental role in generating or supplying therapeutic oxygen across healthcare settings, including hospitals, clinics, and home-care environments. Continued demand for reliable respiratory support, together with increasing preference for equipment that can provide consistent oxygen availability, reinforces the importance of oxygen source technologies within therapy infrastructure.

Oxygen delivery devices represent the fastest-growing product segment as greater emphasis is placed on improving patient comfort, mobility, and the effectiveness of oxygen administration. Innovations in interfaces and delivery systems are enabling more flexible treatment approaches across clinical and home settings, while the increasing use of oxygen therapy outside traditional hospital environments is creating additional demand for convenient and patient-friendly delivery solutions.

End Use Segment Analysis: Home Healthcare (Largest & Fastest-Growing Segment)

Home healthcare held the largest share of the oxygen therapy market and was also the fastest-growing end-use segment in 2026. The segment is benefiting from the broader shift toward decentralized respiratory care, allowing patients requiring ongoing oxygen support to receive treatment in familiar home environments rather than relying solely on institutional care. Portable equipment, easier-to-manage oxygen systems, and improvements in remote patient support are making home-based therapy increasingly practical, while healthcare providers and patients continue to value solutions that can improve treatment convenience and continuity.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Oxygen Source Equipment, Oxygen Delivery Devices	Oxygen Source Equipment	Oxygen Delivery Devices
End Use	Home Healthcare, Non-Home Healthcare	Home Healthcare	Home Healthcare
Application	Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia, Others	Chronic Obstructive Pulmonary Disease	Obstructive Sleep Apnea

Competitive Landscape and Market Positioning

Key companies in the oxygen therapy market:

1. ResMed Inc. (United States)

2. Koninklijke Philips N.V. (Netherlands)

3. Inogen Inc. (United States)

4. Drägerwerk AG & Co. KGaA (Germany)

5. Linde plc (Ireland)

6. Chart Industries Inc. (United States)

7. Fisher & Paykel Healthcare Corporation Limited (New Zealand)

8. GE HealthCare Technologies Inc. (United States)

9. Invacare Corporation (United States)

10. Air Liquide S.A. (France)

The oxygen therapy market is advancing through improved respiratory care technologies and integrated health solutions. Innovation is enhancing treatment delivery efficiency and patient comfort. Collaborative healthcare integration is strengthening home and clinical care models. Continuous development is supporting more comprehensive respiratory management systems.

Industry Development/News

Company Name	Date	Key Development
Sheba Medical Center	May-26	Sheba Medical Center opened Israel's first protected underground hyperbaric oxygen therapy center following a 22 million shekel donation. The facility expands specialized capacity for complex wounds, radiation injuries, and diabetes complications, altering local operational capabilities.
International Hyperbaric Medical Facility Ltd	Jan-26	International Hyperbaric Medical Facility Ltd inaugurated Trinidad and Tobago's initial hard-shell hyperbaric oxygen therapy center. This footprint expansion establishes localized access to advanced HBOT, chronic wound management, and neurological treatments.
Clinton Health Access Initiative (CHAI)	May-25	Public-private health infrastructure efforts expanded Ethiopia's medical oxygen infrastructure from three plants in 2016 to 55 production facilities. This scaled supply chain initiative drastically improves geographic access and industrial-level oxygen availability.
HCG MCC	Jan-25	HCG MCC established a dedicated multi-place Hyperbaric Oxygen Therapy department. The specialized facility accommodates up to four patients simultaneously, expanding institutional treatment capacity for complex recovery, wound healing, and brain injuries.
Pacific Specialist Healthcare (PSH)	Aug-24	Pacific Specialist Healthcare launched a new clinical Hyperbaric Oxygen Therapy service. The integration of advanced HBOT technology expands the company's regional healthcare delivery footprint and clinical service capabilities.
Banaras Hindu University Trauma Centre	Jun-24	Banaras Hindu University Trauma Centre commissioned an advanced Hyperbaric Oxygen Therapy facility. This capital expansion integrates specialized oxygen-based therapeutic infrastructure into its existing trauma care and wound management operations.
Drive DeVilbiss International	May-23	Drive DeVilbiss International commercialized an energy-efficient 10-liter oxygen concentrator designed for rural and semi-urban primary healthcare facilities. The launch scales clinical delivery options within infrastructure-challenged markets.
OMRON Corporation	Jul-22	OMRON Corporation entered the homecare oxygen therapy segment via a novel portable oxygen concentrator using molecular sieve technology. Delivering continuous high-purity oxygen, the device expands the company's competitive positioning in home respiratory management.
CANTA	Nov-22	The Bolivian government selected CANTA oxygen concentrators to supply the high-altitude capital city of La Paz, establishing an critical public procurement distribution channel based on hardware reliability metrics.
Inogen	Nov-24	Inogen released the Rove 4 Portable Oxygen Concentrator featuring a novel fourth flow setting delivering up to 840 ml/min. The product introduction provides material functional differentiation within the competitive portable oxygen therapy portfolio landscape.